{
    "address": "c/o IDEON SCIENCE PARK, Solvegatan 43",
    "city": "Lund",
    "country": "SE",
    "currency": "SEK",
    "cusip": "W0R196101",
    "description": "AegirBio AB engages in the development and commercialization of drug monitoring tests. The company is headquartered in Lund, Skane and currently employs 1 full-time employees. The company went IPO on 2020-06-26. The firm's tests for optimized dosage of biological drugs focused on diseases in neurology, autoimmune diseases and cancer.",
    "employeeTotal": "1.0",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "Biotechnology",
    "ggroup": "Pharmaceuticals, Biotechnology & Life Sciences",
    "gind": "Biotechnology",
    "gsector": "Health Care",
    "gsubind": "Biotechnology",
    "ipo": "2020-06-26",
    "isin": "SE0014401121",
    "logo": "",
    "marketCapitalization": 5757.249,
    "naics": "Scientific Research and Development Services",
    "naicsNationalIndustry": "Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)",
    "naicsSector": "Professional, Scientific, and Technical Services",
    "naicsSubsector": "Professional, Scientific, and Technical Services",
    "name": "AegirBio AB",
    "phone": "",
    "sedol": "BM9G6W6",
    "shareOutstanding": 13.110913,
    "state": "SKANE",
    "ticker": "AEGIR.ST",
    "weburl": "https://aegirbio.com/"
}